Questions and answers on combined oral contraceptives – information for patients
A comprehensive review of the benefits and risks of oral contraceptives was recently carried out paying special attention to the risk of formation of blood clots associated with the use of these medicines.
Hereby, HALMED wants to provide more information on the risk of blood clots associated with use of combined oral contraceptives; including information on conditions increasing the risk of blood clots, information on signs and symptoms of blood clot and information when to tell the doctor or pharmacist about using these medicines.
Taking account that the recent benefit risk ratio referred to formation of blood clots, this document contains a number of information related to this risk.
The data concern only progestogen-containing medicines and not ethynylestradiol or estradiol.
The questions and answers list of combined hormone contraceptives is accessible here.